Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

NCT01473251 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Exudative Macular Degeneration
Diabetic Macular Edema

Interventions

DRUG: Avastin
DRUG: Avastin
DRUG: Lucentis

Sponsor

Vitreo-Retinal Associates, Michigan

Collaborators

[object Object]